Clinical Trials · NCT06738979
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Enrollment
- 408
- Start date
- Mar 2025
- Locations
- 66 sites, China
- Primary endpoint
- Percentage (%) of body weight loss